Dr. Akhila Chagalamari is a medical and pharmacology researcher with expertise spanning clinical pharmacology, pharmacovigilance, clinical research, computational drug discovery, molecular docking, and evidence-based medicine. Her academic and research interests integrate experimental, computational, and clinical approaches to address contemporary challenges in pharmacology and biomedical sciences. She has also developed clinical and research competencies through specialized training in Geriatrics and Gerontology, Good Clinical Practice (GCP), Biomedical Research, BLS, ACLS, and adverse drug reaction monitoring.

Research & Dissertation

Dr. Chagalamari's dissertation focused on “Anti-tumor Efficacy of Anacyclus pyrethrum in the Modulation of Nrf2 Activity using EAC Solid Tumor In Vivo Model,” conducted under the guidance of Dr. M. K. Jayanthi, Professor and Head, Department of Pharmacology, JSS Medical College, Mysuru. Her work demonstrates an interest in molecular mechanisms of cancer and the exploration of pharmacological interventions through experimental models.

Clinical Research & Pharmacovigilance

She has contributed to clinical research as a Study Coordinator for a Phase 2/3 observer-blind, randomized, controlled study evaluating the safety and immunogenicity of COVOVAX, sponsored by Serum Institute of India Pvt. Ltd. in an ICMR project. Her additional expertise includes clinical trial coordination, ICH-GCP, pharmacovigilance, materiovigilance, ADR reporting, and clinical research methodology.

Research Contributions & Publications

Dr. Chagalamari has contributed to research publications covering anticancer pharmacology, gut microbiota and depression, antimicrobial utilization and resistance, computational drug discovery, polypharmacology, asthma therapeutics, pharmacovigilance, myasthenia gravis, adverse drug events, and apoptosis in cancer. Her publications include articles in journals such as Indian Journal of Pharmacy and Pharmacology, Current Medicinal Chemistry, Journal of Clinical and Diagnostic Research, Perspectives in Clinical Research, and Bioinformation.

Her research demonstrates a multidisciplinary approach combining clinical evidence, systematic and umbrella reviews, pharmacological investigation, computational modelling, and real-world pharmacovigilance data.

Chapter title

• Geriatric Pharmacology in Women: Physiological Transitions, Aging Biology and Drug Response Dynamics — in Advancing Women’s Health
• Targeting the Undruggable: Sotorasib and the Pharmacologic Conquest of KRAS
• Drug Promotion Activities: Guidelines, Rules and Regulations
• Liver Failure Patients and PK/PD Changes: Therapeutic Strategies
• Development of Vaccines: Vaccine Trials and Regulations
• PCSK9 Inhibitors and Recent Advances in Hypolipidemic Drugs
• Toxicogenomics
• Recent Update in XDR-TB

Standard Operating Procedures: SOPs

1. Hand Steadiness Tester

2. Electronic Tachistoscope

3. Mirror Drawing Apparatus with Digital Clock and Error Counter

Guest Lecture at Sibar Dental College

Computational & Innovative Research

A significant aspect of her research profile is her work in molecular docking and computational drug design. She has undertaken research involving molecular docking of drug molecules with therapeutic targets and has conducted hands-on workshops covering protein and ligand preparation, binding-site prediction, docking workflows, protein–ligand interaction analysis, and binding-affinity interpretation.

She has also worked on computational investigations involving formoterol and NRF-1, bacterial MreB targeting, SARS-CoV-2 RdRp, and other drug-discovery applications.

Academic Presentations & Professional Engagement

Dr. Chagalamari has presented her research at national and international scientific forums, including the World Congress on Geriatrics and Gerontology, APPSCON, IPSCON 2024 at AIIMS New Delhi, Anusandhan Divas at AIIMS Mangalagiri, and MPSCON International Conference 2026. Her presentations address topics ranging from geriatric substance abuse and gut microbiota to innovative immunotherapy, computational pharmacology, and antimicrobial resistance.

She is also involved in professional service as an Executive Committee Member of the Government Doctors Association of Andhra Pradesh, representing Government Medical College, Piduguralla. Since 2026, she has additionally served as a Scholar Council Member and Peer Reviewer with ETERNO PRESS, contributing to scientific manuscript evaluation and recommendations for research improvement.

Ongoing Research

Her ongoing projects demonstrate continued engagement with socially relevant and translational research areas, including medication reuse and disposal, postgraduate medical thesis research, antihypertensive drug evaluation, pharmacology education, and computational investigation of neuroprotective mechanisms in asthma.

Training & Certifications

Her professional development includes certifications and training in:

• ICH-GCP Guidelines for Clinical Research
• Basic Course in Biomedical Research (BCBR)
• Basic Life Support (BLS)
• Advanced Cardiac Life Support (ACLS)
• Pharmacovigilance and ADR Reporting
• Geriatrics and Gerontology
• Computational Structure-Based and Ligand-Based Drug Design
• Advanced Good Clinical Practice
• Gamification in Medical Education

Eligibility for Innovative Researcher of the Year 

Dr. Akhila Chagalamari demonstrates strong eligibility for the Innovative Researcher of the Year Award in Scientific Laurels through her multidisciplinary contributions to pharmacology and biomedical research. Her profile combines experimental cancer research, clinical trials, pharmacovigilance, systematic and umbrella reviews, molecular docking, computational drug discovery, antimicrobial resistance research, and real-world safety-data analysis. Her peer-review activities, scientific presentations, publications, professional association involvement, workshops, and ongoing research projects further demonstrate sustained engagement with innovative and translational scientific work.

Overall, Dr. Akhila Chagalamari represents an emerging multidisciplinary researcher whose integration of clinical, experimental, computational, and evidence-based approaches provides a strong basis for consideration for the Innovative Researcher of the Year recognition in Scientific Laurels.